Clinical review report Insulin degludec (Tresiba) (Novo Nordisk Canada Inc)
The objective of the current review is to perform a systematic review of the beneficial and harmful effects of insulin degludec (IDeg) for the treatment of adults with diabetes mellitus to improve glycemic control
Corporate Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2017, December 2017
|
Edition: | Version 1.0 |
Series: | CADTH common drug review
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | The objective of the current review is to perform a systematic review of the beneficial and harmful effects of insulin degludec (IDeg) for the treatment of adults with diabetes mellitus to improve glycemic control |
---|---|
Physical Description: | 1 PDF file (170 pages) illustrations |